DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Soaanz is a drug marketed by Sarfe Pharms and is included in one NDA. There is one patent protecting this drug.
This drug has two patent family members in two countries.
The generic ingredient in SOAANZ is torsemide. There are sixteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the torsemide profile page.
A generic version of SOAANZ was approved as torsemide by TEVA on May 14th, 2002.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Sarfe Pharms||SOAANZ||torsemide||TABLET;ORAL||213218-001||Jun 14, 2021||RX||Yes||Yes||⤷ Free Forever Trial||⤷ Free Forever Trial||Y||⤷ Free Forever Trial|
|Sarfe Pharms||SOAANZ||torsemide||TABLET;ORAL||213218-002||Jun 14, 2021||RX||Yes||No||⤷ Free Forever Trial||⤷ Free Forever Trial||Y||⤷ Free Forever Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|